HolleLMSegalEMJeffersKD. The expanding role of the oncology pharmacist. Pharmacy (Basel)2020; 8: 130.
2.
KnezLLaaksonenRDugganC. Evaluation of clinical interventions made by pharmacists in chemotherapy preparation. Radiol Oncol Dec 2010; 44: 249–256.
3.
JohnsonLKhattabSStrawbridgeJ, et al.Pharmacist prescribing in cancer services: a scoping review. Research in Social and Administrative Pharmacy 2025/05/09/ 2025. doi:10.1016/j.sapharm.2025.05.004
4.
SourisseauAFronteauCBonsergentM, et al.Practicing and evaluating clinical pharmacy in oncology: where are we now? A scoping review. Res Social Adm Pharm May 2023; 19: 699–706.
5.
FentieAMHulukaSAGebremariamGT, et al.Impact of pharmacist-led interventions on medication-related problems among patients treated for cancer: a systematic review and meta-analysis of randomized control trials. Res Soc Admin Pharm2024; 20: 487–497.
6.
AliTSiddiquiABhuttaOA, et al.Improving clinical pharmacist performance in oncology care through education on pharmaceutical care plans documentation: a Pre-post interventional study. Inquiry2025; 62: 469580251335819.
7.
Ahmer RazaMAzizSNoreenM, et al.A portrait of the pharmacy profession globally: pharmacist universal professional identity and establishment of global pharmacy council. Innov Pharm2022; 13. DOI: 10.24926/iip.v13i1.4502.
8.
DahalUKKhadkaKNeupaneK, et al.Cancer risk in Nepal: an analysis from population-based cancer registry of urban, suburban, and rural regions. J Cancer Epidemiol2024; 2024: 4687221.
9.
SungHFerlayJSiegelRL, et al.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin May 2021; 71: 209–249.
10.
FerlayJColombetMSoerjomataramI, et al.Cancer statistics for the year 2020: an overview. Int J Cancer2021; 5: 778–789.
11.
PalaianSKhanalS.Pharmacy students feed back on hospital and clinical pharmacy workshop: a study from Nepal. The Pharma Review. 2008:169–184.
12.
KhanalSPoudelASharanK, et al.Oncology pharmacy practice in a teaching hospital in Nepal. J Oncol Pharm Pract2010; 16: 75–79.
13.
ShresthaSShresthaSKhanalS.Establishment of the first cancer hospital-based pharmacovigilance center in Nepal. Res Social Adm Pharm2018;14:1088–1089.
14.
ShresthaSShakyaDPalaianS. Clinical pharmacy education and practice in Nepal: a glimpse into present challenges and potential solutions. Adv Med Educ Pract2020; 11: 541–548.
15.
ShresthaSShresthaSSapkotaB, et al.Reintroduction of post-baccalaureate doctor of pharmacy (PharmD, post-bac) program in Nepal: exploration of the obstacles and solutions to move forward. Adv Med Educ Pract2022; 13: 159–166.
KhadkaSMalekuKThapaP.Implementing hospital pharmacy service guideline in Nepal: a critical analysis. Hosp Pharm2023; 58: 527–529.
18.
PathakNBasyalB. Clinical clerkship at an oncology hospital based on the curriculum of a clinical pharmacy program from a university belonging to low-middle-income country: insights from a pharmacy program experience. J Oncol Pharm Pract Jul 2023; 29: 1227–1233.
19.
ShresthaSSharmaSBhasimaR, et al.Impact of an educational intervention on pharmacovigilance knowledge and attitudes among health professionals in a Nepal cancer hospital. BMC Med Educ2020; 20: 79.
20.
ShresthaSShresthaRAbidiA, et al.Workshop on adverse drug reaction reporting, pharmacovigilance and its implementation in cancer hospital in Nepal: an event report. Adv Med Educ Pract2020; 11: 9–14.
21.
ShresthaRPalaianSSapkotaB, et al.A nationwide exploratory survey assessing perception, practice, and barriers toward pharmaceutical care provision among hospital pharmacists in Nepal. Sci Rep2022; 12: 16590.
22.
ShresthaSShakyaSKhatiwadaAP. An urgent necessity for clinical pharmacy services in cancer care in Nepal. JCO Glob Oncol2020; 6: 1392–1393.
23.
TamangRBharatiLKhatiwadaAP, et al.Pattern of adverse drug reactions associated with the use of anticancer drugs in an oncology-based hospital of Nepal. Jma j2022; 5: 416–426.
24.
ShresthaSShakyaRShresthaS, et al.Adverse drug reaction due to cancer chemotherapy and its financial burden in different hospitals of Nepal. Age (Omaha). 2017;73:59.8.
25.
KunworPBasyalBPathakN, et al.Study to evaluate awareness about medication errors and impact of an educational intervention among healthcare personnel in a cancer hospital. J Oncol Pharm Pract2025; 31: 347–354.
26.
ShresthaSSapkotaSTeohSL, et al.Clinical pharmacist interventions on pain management in cancer patients (PharmaCAP) in low resource settings: a multicenter feasibility-pilot randomized controlled trial. Support Care Cancer2024; 32: 28.
27.
ShresthaSBlebilAQTeohSL, et al.Clinical pharmacists’ intervention on pain management in cancer patients (PharmaCAP trial): study protocol for a randomized controlled trial. J Pharm Policy Pract2023; 16: 14.
28.
SharmaSKhanalTShresthaS, et al.A celebration of world pharmacist day 2018 focusing to strengthen the pharmacy services at an oncology-based hospital in Nepal: inspiration for others in developing countries. Res Social Adm Pharm2019; 15: 117–118.
29.
DhunganaSPathakNBasyalB, et al.Pediatric oncology services in Nepal: a special focus on pharmacy practice. J Oncol Pharm Pract2024; 30: 425–435.
30.
BhuvanKCSubishPMohamed IzhamMI. Pharmd education in Nepal: the challenges ahead. Am J Pharm Educ2011; 75: 8c.
31.
SpasovskaOBardinCKuzmanovićM, et al.Clinical oncology pharmacy has become a reality: results of a member survey of the European Society of Oncology Pharmacy Global. Eur J Oncol Pharm2024; 7. DOI: https://doi.org/10.1097/OP9.0000000000000055.
32.
ShresthaSGanSHPaudyalV, et al.Current practices, gaps, and opportunities on the role of clinical pharmacists in cancer pain management: perspectives from Nepal. J Oncol Pharm Pract2023; 29: 2049–2056.
KhatiwadaAPShresthaSSapkotaB, et al.Continuing pharmacy education: exploring the Status and future prospects in Nepal. Adv Med Educ Pract2022; 13: 419–425.
35.
PatelHPerrySBaduE, et al.A scoping review of interprofessional education in healthcare: evaluating competency development, educational outcomes and challenges. BMC Med Educ2025; 25: 09.
36.
World Health Organization. Framework for action on interprofessional education and collaborative practice. 2010. https://www.who.int/publications/i/item/framework-for-action-on-interprofessional-education-collaborative-practice.
37.
EastyACCoakleyNChengR, et al.Safe handling of cytotoxics: guideline recommendations. Curr Oncol2015; 22: e27–e37.
38.
PoudyalBSDulalSShilpakarR, et al.Highlights from ecancer choosing wisely Nepal 2022: critical appraisal skills for evidence-based practice, 24th-25th September 2022, Kathmandu, Nepal. Ecancermedicalscience2022; 16: 1478.
39.
ElmoreCEAcharyaSCDulalS, et al.Building a ‘virtual library': continuing a global collaboration to strengthen research capacity within Nepal and other low- and middle-income countries. Glob Health Action2022; 15: 2112415.
